Optimising the management of multiple myeloma in the early relapsed/refractory setting

  • calender Thursday, 30th May, 2024
  • clock 16:00h - 18:55h (UTC)

Prof. Karthik Ramasamy

Prof. Karthik Ramasamy
Hematologist

Oxford University Hospitals NHS Trust

United Kingdom
More information

Prof. Aurore Perrot

Prof. Aurore Perrot
Hematologist

University of Toulouse, France

France
More information

Prof. Hermann Einsele

Prof. Hermann Einsele
Hematologist Oncologist

University of Würzburg, Germany

Germany
More information

Dr Joshua Richter

Dr Joshua Richter
Hematologist

Icahn School of Medicine at Mount Sinai

United States
More information

A virtual Experts Knowledge Share on the topic of ‘Optimising the management of multiple myeloma in the early relapsed/refractory setting’ with Scientific Committee Assoc. Prof. Karthik Ramasamy (UK), Prof. Aurore Perrot (France), Prof. Hermann Einsele (Germany) and Assoc. Prof. Joshua Richter (USA)

Topics of conversation include:

  1. Challenges of optimising treatment for early relapsed/refractory multiple myeloma (RRMM) in the era of multiple novel therapies
  2. Current treatments for early RRMM: Linking mechanism of action to efficacy
  3. Best practices in combining and sequencing therapies for optimal outcomes in RRMM
  4. Insights from clinical practice on how to manage tolerability and safety
  5. Patient case study discussions

This event is in collaboration with LYMPHOMA & MYELOMA CONNECT, an international group of experts in the field of hematological malignancies.

You will also have the opportunity to contribute to the discussion on this important topic. An honorarium of 100 EUROS is offered to HCPs for active participation and for completing the pre-meeting survey.

In registering for this meeting you are joining the COR2ED community. We will keep you informed of future meetings and programmes of interest.

Please submit your patient case study/questions for the faculty to selina.gill@cor2ed.com

endorsement
Brought to you by
LYMPHOMA & MYELOMA CONNECT cme

LYMPHOMA & MYELOMA CONNECT Is an initiative of COR2ED. This programme is supported by an Independent Medical Education Grant from Menarini Stemline Oncology

Stay tuned for new events

Stay updated!